BCM
OGI

Bayesian Capital Management’s Organigram Holdings OGI Stock Holding History

Bayesian Capital Management’s Portfolio OGI Stock Details OGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,575
Closed -$61K – 930
2022
Q2 		$61K Buy
+16,575
New +$84.5K 0.01% 710

Other funds holding OGI

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayesian Capital Management's OGI Position: Q3 2022 in Review

Bayesian Capital Management sold out of Organigram Holdings (OGI) in Q3 2022, closing a stake of 16,575 shares — an estimated $61K sold.

Bayesian Capital Management first reported a position in OGI in Q2 2022 and held it in 1 quarter. The position peaked at $61K in Q2 2022. 120 funds tracked by Wall St. Rank hold OGI as of Q3 2022.

  • Bayesian Capital Management reported no remaining Organigram Holdings position as of Q3 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 16,575 Organigram Holdings shares in Q3 2022, an estimated $61K.
  • Bayesian Capital Management first reported a position in Organigram Holdings in Q2 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Organigram Holdings position peaked at $61K in Q2 2022.
  • 120 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.